Hosted on MSN51m
NICE green lights two blood cancer therapies for NHS useBMS’ Breyanzi and Amgen’s Blincyto will now be available to patients in England with certain types of blood cancer.
Researchers have found Brukinsa to be a potentially safer alternative for patients with chronic lymphocytic leukemia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback